Catherine J. Mackey - 24 Jun 2025 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Role
Director
Signature
/s/ Andres Ruiz Briseno, as Attorney-in-Fact for Catherine J. Mackey
Issuer symbol
IDYA
Transactions as of
24 Jun 2025
Net transactions value
$0
Form type
4
Filing time
26 Jun 2025, 16:54:45 UTC
Previous filing
04 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MACKEY CATHERINE J Director C/O IDEAYA BIOSCIENCES, INC., 5000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO /s/ Andres Ruiz Briseno, as Attorney-in-Fact for Catherine J. Mackey 26 Jun 2025 0001645330

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDYA Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 24 Jun 2025 Common Stock 20,000 $21.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date.